Moderna Inc

MRNA · Moat type: REGULIERUNG

MoatScore

1/10

Fair Value

n/a

Margin of Safety

n/a

Rating

MEIDEN

GESCHÄFTSMODELL Moderna develops and markets mRNA-based pharmaceuticals and vaccines, generates revenue primarily from the sale of approved products (COVID-19 vaccine) as well as from licensing fees and government support contracts, and seeks to expand the mRNA platform technology to additional disease areas.

View full analysis →

🔒 Detailed AI analysis, peer comparison, capital allocation, crisis resilience & PDF report for Pro members.

Not investment advice. Analyses are research, not a recommendation. Valuations may be erroneous or incomplete. © MoatScan.ai — proprietary methodology.